Colesevelam ( DrugBank: Colesevelam )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 96 | クローン病 | 2 |
| 260 | シトステロール血症 | 1 |
96. クローン病
臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2009-010727-91-DE (EUCTR) | 01/03/2011 | 05/06/2012 | Colesevelam, which is a medication which binds bile acid, to test in patients with Crohns disease | Colesevelam for the treatment of bile acid malabsorption in patients with Crohn’s disease (Colesevelam für die Therapie der Gallensäuren-Malabsorption bei M. Crohn-Patienten) | Morbus Crohn MedDRA version: 14.1;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders | Trade Name: Cholestagel Product Name: Cholestagel Product Code: EU/1/03/268/002 INN or Proposed INN: Colesevelam | LMU München, Campus Großhadern | NULL | Not Recruiting | Female: yes Male: yes | Germany | ||||
| 2 | NCT01203254 (ClinicalTrials.gov) | October 2010 | 15/9/2010 | Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease | Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease | Crohns Disease;Bile Acid Malabsorption | Drug: Colesevelam;Drug: Placebo | Florian Beigel | NULL | Terminated | 18 Years | 65 Years | Both | 34 | Phase 4 | Germany |
260. シトステロール血症
臨床試験数 : 13 / 薬物数 : 13 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01948648 (ClinicalTrials.gov) | February 6, 2018 | 6/9/2013 | Effects of Fish Oil and Colesevelam (STAIR7007) | Effects of Fish Oil, Colesevelam and Combination Therapy on Sterol Metabolism in Sitosterolemia | Sitosterolemia | Drug: Colesevelam;Dietary Supplement: Fish Oil;Drug: Combination of fish oil and colesevelam | University of Manitoba | NULL | Active, not recruiting | 8 Years | N/A | All | 13 | N/A | Canada |